titlesubmit dateissue date
Now showing items 1-7 of 7
Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
Oncogenic dependence of glioma cells on kish/TMEM167A regulation of vesicular trafficking.
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.